THE EFFECT OF CY1503, A SIALYL LEWIS(X) ANALOG BLOCKER OF THE SELECTIN ADHESION MOLECULES, ON INFARCT SIZE AND NO-REFLOW IN THE RABBIT MODEL OF ACUTE MYOCARDIAL INFARCTION REPERFUSION/
Y. Birnbaum et al., THE EFFECT OF CY1503, A SIALYL LEWIS(X) ANALOG BLOCKER OF THE SELECTIN ADHESION MOLECULES, ON INFARCT SIZE AND NO-REFLOW IN THE RABBIT MODEL OF ACUTE MYOCARDIAL INFARCTION REPERFUSION/, Journal of Molecular and Cellular Cardiology, 29(8), 1997, pp. 2013-2025
CY1503, an analogue of sialyl-Lewis(x), is an inhibitor of the selecti
n adhesion molecules, CY1503 has been found to limit myocardial infarc
t size in canine and feline models. However, the effect of CY1503 on t
he ''no-reflow'' phenomenon is still unknown, Anesthetised rabbits wer
e subjected to 30 min of coronary artery occlusion and 4 h of reperfus
ion, Protocol 1: after 27 min of ischemia, rabbits were randomised to
an iv bolus of either CY1503 (30 mg/kg) (n = 9) or saline (n = 9), Pro
tocol 2: rabbits were randomly given two iv boluses of CY1503 (30 mg/k
g) (n = 6) or saline (n = 6), administered after 10 and 25 min of isch
emia. Protocol 3: after 27 mill of ischemia rabbits were randomly give
n an iv bolus of CY1503 (30 mg/kg) (n = 6) and infusion of 20 mg/kg ov
er 4 h or saline bolus + infusion (n = 6). Regional myocardial blood f
low (RMBF) was assessed after 30 min and 4 h of reperfusion. The risk
zone (RZ) was assessed by blue dye and the necrotic zone (NZ) by tetra
zolium staining, RMBF: protocol 1: RMBF in the RZ was 2.19 +/- 0.33 v
2.34 +/- 0.34 ml/g/min in CY1503 and controls al 30 min (P=0.75), and
0.43+/-0.07 v 0.41+/-0.08 at 4 h of reperfusion (P=0.85). The correspo
nding results for protocol 2 were 1.77 +/- 0.29 v 1.53 +/- 0.34 at 30
min (P = 0.61) and 0.53 +/- 0.16 v 0.91 +/- 0.55 at 4 h (P = 0.53), RM
BF in RZ in protocol 3 were 1.52 +/- 0.25 v 1.32 +/- 0.20 at 30 min (P
= 0.56) and 0.30 +/- 0.05 v 0.29 +/- 0.09 (P = 0.90) after 4 h of rep
erfusion. The RZ was similar in both groups in all protocols. The NZ/R
Z ratio was comparable in the CY1503 and control group in all three pr
otocols (0.32 +/- 0.04 v 0.37 +/- 0.06, 0.37 +/- 0.08 v 0.33 +/- 0.07,
and 0.51 +/- 0.05 v 0.38 +/- 0.05 in protocols 1, 2, and 3, respectiv
ely), CY1503 did not limit infarct size or prevent the ''no-reflow'' p
henomenon in the rabbit. (C) 1997 Academic Press Limited.